METHODS	This study is a subsidiary analysis of the PROGRESS trial-a randomized , placebo-controlled trial that established the beneficial effects of BP lowering in patients with cerebrovascular disease ; 6105 patients were randomly assigned to either active treatment ( perindopril for all participants plus indapamide for those with neither an indication for nor a contraindication to a diuretic ) or matching placebo .\